Back to results
US 2013/0158122 A1Published application
EP2 Agonist from Non-Prostanoid Structures Designed as PGE2 Antagonists
AssigneeAllergan, Inc.
InventorsDavid F. Woodward, Jenny W. Wang
Life of this patent
Estimating the term…
Abstract
A method of treating ocular hypertension, lowering intraocular pressure, pain or inflammation, comprising administering to a mammal a pharmaceutical composition of an EP2-receptor agonist represented by
Claims3
A method of treating one of the following conditions selected from the group consisting of ocular hypertension, lowering intraocular pressure, pain, and inflammation, the method comprising administering to a mammal in need of such treatment a pharmaceutical composition comprising a compound represented by:
Dependencies are inferred from the claim text.